Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7414 p211
19 August 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Patient fraud cut by more than 50 per cent

Checks on prescription charge exemptions

Checks on prescription charge exemptions have saved £70m

Losses to the NHS due to patients making false claims for exemption from prescription, dental and optical charges have more than halved since steps to prevent evasion were introduced in 1998. The past eight years have seen annual losses cut from £170m to £76m.

In 1998, the NHS was losing £117m a year due to patients avoiding prescription charges. This loss has now been cut to £47m a year. Annual dental charge losses have been cut from £40.3m to £21.1m and optical charge losses from £13.25m to £8.2m.

To the end of 2004–05, the total reduction in fraud amounts to almost £675m — a 13:1 return on the NHS CFS budget.

Jim Gee, managing director of the NHS CFS, added: “These figures show the impact that a comprehensive, professional approach can have. … We have worked closely with doctors, pharmacists, dentists and opticians to achieve these results and I would like to thank them for their support.”

Royal Pharmaceutical Society President Hemant Patel said: “We would like to acknowledge the hard work of pharmacists across the country in achieving this reduction. We fully support the good work of the NHS Counter Fraud Service in protecting valuable NHS resources, so that they are put to good use in delivering high quality health care. We will continue to work with the NHS CFS to further these gains.”

Back to Top


©The Pharmaceutical Journal